Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...

Significant organizational changes are necessary in order to embrace a model-based drug-development approach. The development pathway of new drugs seems to be disruptive, with little communication ...

AI accelerates drug development, cutting costs and boosting success rates. Discover how AI is reshaping the future of ...

The U.S. Food and Drug Administration (FDA) recently issued two new guidance documents governing details of the Accelerated Approval ...

To have any impact, patient engagement needs to start with the drug development pathway, not at the point of licensing. That’s especially true in the rare disease space, where the unmet need is ...

Experts say A.I. is transforming the industry. Traditionally, drug development is expensive - often taking billions of dollars and years of experimentation and trials. And there is no guarantee ...

A team of researchers from the Keck School of Medicine of USC has unlocked the details of a cellular pathway that triggers ...

independent team of Australian scientists won a rare approval – upending the normal drug development pathway. The success of their audacious strategy paves the way for charities and not-for ...

Extending their collaboration, Genialis and Debiopharm continue working towards a patient classifier to support WEE1 clinical development ... landscape of cancer drug targets, including DDR.

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...